131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past.

Saved in:
Bibliographic Details
Title: 131I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future past.
Authors: Fabozzi F; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Villani MF; Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Del Bufalo F; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Altini C; Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Cannatà V; Medical Physics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Davide C; Medical Physics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Pizzoferro M; Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Drago M; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., D'Antonio F; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Triumbari EKA; Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Di Giannatale A; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Vennarini S; Pediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Mastronuzzi A; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., De Ioris MA; Paediatric Haematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Electronic address: mantonietta.deioris@opbg.net., Garganese MC; Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2025 Mar; Vol. 207, pp. 104606. Date of Electronic Publication: 2024 Dec 26.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0461
DOI:10.1016/j.critrevonc.2024.104606